In cerebral ischemia, silencing PAR1 reduces neurological deficits, reduces BBB leakage, and decreases neuronal degeneration [74], but PAR1 inhibitors also increase hemorrhagic transformation [75]. This evidence concerns the gene F2R and Cerebral ischemia.